TOMM40 and fatty liver disease: In mice it has been reported that overexpressing Srebf1c resulted in fatty liver disease without upregulation of hepatic LDLR gene expression [51], indicating that with Tomm40 KD in vivo there may be mechanisms contributing to Ldlr upregulation other than Srebf1c.